Wegovy 1.7 MG/0.75 ML pen 0.75ML
Ended Awarded
- Contract number
- SPE2DB25FLHB4
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,632
Award facts
- Contract value 100% obligated
- $25,631.62 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $25,631.62 to AmerisourceBergen Drug Corp for Wegovy 1.7 mg/0.75 ml pen injectors on September 2, 2025, with an ultimate completion date of September 3, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement supporting military and veteran healthcare systems. The SPE2DX IDC functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. This delivery order for Wegovy, a medication used in weight management and diabetes treatment, exemplifies the company's role in fulfilling specialized pharmaceutical needs for the Defense Health Agency and other federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FLHB4?
SPE2DB25FLHB4 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 2, 2025.
How much is contract SPE2DB25FLHB4 worth?
The government has obligated $25,632 on SPE2DB25FLHB4.
Is contract SPE2DB25FLHB4 an order under another contract?
Yes. SPE2DB25FLHB4 is a delivery order under SPE2DB22D1002, an indefinite delivery contract.
Was contract SPE2DB25FLHB4 competed?
The extent of competition for SPE2DB25FLHB4 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award